Results
Results of the study
Results
The results of the study will gradually be entered here.
https://www.aerzteblatt.de/archiv/221932/SARS-CoV-2-Seropraevalenz-in-Deutschland
2. Rodiah, I., Vanella, P., Kuhlmann, A., Jaeger, V. K., Harries, M., Krause, G., . . . Lange, B. (2021). Age-specific Contribution of Contacts to Transmission of SARS-CoV-2 in Germany. medRxiv
3. Dulovic, A., Kessel, B., Harries, M., Becker, M., Ortmann, J., Griesbaum, J., … & Strengert, M. (2022). Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany. Frontiers in immunology, 13.
4. Junker, D., Becker, M., Wagner, T. R., Kaiser, P. D., Maier, S., Grimm, T. M., . . . Schneiderhan-Marra, N. (2022). Antibody binding and ACE2 binding inhibition is significantly reduced for both the BA1 and BA2 omicron variants. Clinical Infectious Diseases.
5. Beermann, S., Dörr, M., Grill, E., Karch, A., Lange, B., & Zeeb, H. (2022). Coronapandemic: the role of epidemiologic research in public health crises. Deutsches Ärzteblatt International, 119(17), A-753.
SARS-CoV-2 seroprevalence in Germany
A population-based sequential study in seven regions
SARS-CoV-2 seroprevalence in Germany—a population-based sequential study in seven regions
Dtsch Ärzteebl Int 2021; 118:824-31; DOI: 10.3238/arztebl.m2021.0364
Your browser can not display embedded frames: You can access the embedded page using the following link: Server dashboard
